Renascience Inc. (TYO:4889)
Japan flag Japan · Delayed Price · Currency is JPY
1,311.00
+2.00 (0.15%)
Aug 27, 2026, 11:30 AM JST

Renascience Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
6868132194100139
Revenue Growth
-33.33%-48.48%-31.96%94.00%-28.06%-33.49%
Gross Profit
646412816510080
Operating Income
-337-357-179-252-334-211
Net Income
-317-301113-258-335-254
Earnings Per Share
-24.12-23.378.89-20.30-26.35-22.30
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
3,2043,4021,7992,0262,2122,386
Total Debt
---356309199
Net Cash (Debt)
3,2043,4021,7991,6701,9032,187
Net Cash Growth
91.40%89.11%7.72%-12.24%-12.99%297.64%
Net Cash Per Share
243.75264.17141.52131.38149.70192.03

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--291-176-230-284-230
Capital Expenditures
----1-2-1
Free Cash Flow
--291-176-231-286-231
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
94.12%94.12%96.97%85.05%100.00%57.55%
Operating Margin
-495.59%-525.00%-135.61%-129.90%-334.00%-151.80%
Pretax Margin
-464.71%-441.18%108.33%-132.47%-334.00%-182.01%
Profit Margin
-466.18%-442.65%85.61%-132.99%-335.00%-182.73%
FCF Margin
--427.94%-133.33%-119.07%-286.00%-166.19%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--117.89---
PS Ratio
265.21339.97100.9224.9756.9540.79